2.32% -0.0118

Citius Pharmaceuticals Inc (CTXR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CTXR Giù? Forum Previsione Frazionamento azionario

Perché le azioni Citius Pharmaceuticals Inc (CTXR) sono in ribasso?

Abbiamo notato un calo di 5.07% nelle azioni di Citius Pharmaceuticals Inc (CTXR) durante la sessione di negoziazione di 2024-09-11. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!

2023-09-13:

Citius Pharmaceuticals Inc Stock (CTXR) dropped by 6.48% from $0.7808 to $0.7302 in the trading on Wednesday September 13, 2023. The reason why CTXR stock down today is following the mourning of loss of Board member Howard Safir. Citius announced the passing of longtime board member, Howard Safir, who passed away on Monday. Mr. Safir joined the Citius Board of Directors in 2014, providing invaluable counsel to the Citius management team for nearly a decade. He was a passionate advocate for the company's mission to develop and commercialize first-in-class critical care products.

2023-05-04:

Citius Pharmaceuticals Inc Stock (CTXR) dropped by 16.11% from $1.49 to $1.25 in the trading on Thursday May 4, 2023. The reason why CTXR stock down today is due to the announcement of stock offering. Citius announced to enter into definitive agreements for the purchase of an aggregate of 12,500,001 shares at a purchase price of $1.20 per share and accompanying warrant in a registered direct offering. The closing of the offering is expected to occur on or about May 8, 2023. The aggregate gross proceeds to the Company from the offering are expected to be approximately $15 million